Early combination of pulmonary vasodilators prevents chronic kidney disease progression in connective tissue disease-associated pulmonary hypertension.
Hironari HanaokaSho IshigakiHiroshi TakeiKazuoto HiramotoShuntaro SaitoYasushi KondoJun KikuchiYuko KanekoTsutomu TakeuchiPublished in: International journal of rheumatic diseases (2021)
Early combination therapy is associated with a lower incidence of CKD progression in patients with CTD-associated PH.